Global Skin Cancer Diagnosis and Therapeutics Market Analysis, Trends and Opportunities 2019-2022
A new market study, titled “Global Skin Cancer Diagnosis and Therapeutics Market Analysis, Trends and Opportunities 2019-2022” has been featured on WiseGuyReports.
The global skin cancer diagnosis market is anticipated to
generate $XX million by 2023. Skin cancer is the uncontrolled development of
anomalous skin cells. It happens when unrepaired DNA harm to skin cells
(frequently caused by bright radiation from daylight or tanning beds) triggers
transformations, or hereditary imperfections, that lead the skin cells to
duplicate quickly and frame threatening tumors.
According to the skin cancer foundation each year in the
U.S. more than 5.4 million instances of nonmelanoma skin disease are dealt with
in more than 3.3 million people. Every year, there are more new instances of
skin cancer than the joint number of tumors of the breast, prostate, lung and
colon. In the vicinity of 40 and 50 percent of Americans who live to age 65
will have either basal cell carcinoma or squamous cell carcinoma. Basal cell
carcinoma (BCC) is the most widely recognized type of skin cancer. More than 4
million cases are analyzed in the U.S. each year. Squamous cell carcinoma is
the second most prevalent type of skin cancer. More than 1 million cases occur
in the U.S. each year. Actinic keratosis is the most widely recognized
pre-cancer; it affects more than 58 million Americans. Around 90% of
non-melanoma skin tumors are related to exposure to bright (UV) radiation from
the sun. The yearly cost of treating skin malignancies in the U.S. is assessed
at $8.1 billion: about $4.8 billion for non-melanoma skin growths and $3.3
billion for melanoma.
The exposure of human skin with the UV rays is considered to
be one of the major causes of skin cancer. There are several factors that are
driving the market such as rising incidences of skin cancer, hereditary causes
including genetic disorder, utilization of combined therapy. The major factor
that drives the market is that when the sun rays that is the ultra violet rays
comes in contact with skin may cause skin cancer.
The skin cancer diagnosis and therapeutics market has been
segmented as by type, by treatment, by diagnosis, by stages and by end user. On
the basis type the market has been bifurcated as Actinic Keratoses (AK), based
cell carcinoma (BCC), squamous cell carcinoma (SCC), Melanoma. According to the
therapy the market has been bifurcated as chemotherapy, targeted therapy,
immunotherapy, radiotherapy, freezing, scraping and others. Based on diagnosis
the market has been bifurcated as CT-scan, X-rays, dermatoscopy, sentinel lymph
node biopsy, blood test and others On the basis of end user, the market has
been bifurcated as multispecialty hospitals, cancer research centers and
clinics.
Geographically, the worldwide skin cancer diagnosis and
therapeutics showcase is divided into North America, Europe, Asia-Pacific, and
the Rest of the World., Asia Pacific market is considered to be the fastest
growing market globally. The rise in the number of cancer patients in the APAC
region is considered to rise eventually enabling the skin cancer diagnosis and
therapeutics market to grow. The North America and Europe are considered to be
the dominating markets due to various factors such as high healthcare
expenditure, development in the technology, support from government, rise in
the key players and various other factors.
The key players in the skin cancer diagnosis and
therapeutics market Include Bristol Myers Squibb Co., Aqua Pharmaceuticals LLC,
AstraZeneca, GlaxoSmithKline, and so on.
MARKET SEGMENTATION:
Global skin cancer diagnosis and therapeutics market is
segmented on the basis of, type, by therapies, by diagnosis, by end user and
regional outlook.
Global Skin Cancer Diagnosis and Therapeutics Market
Research and Analysis, by Type
Global Skin Cancer Diagnosis and Therapeutics Market
Research and Analysis, by Therapies
Global Skin Cancer Diagnosis and Therapeutics Market
Research and Analysis, by Diagnosis
Global Skin Cancer Diagnosis and Therapeutics Market
Research and Analysis, by End User
Global Skin Cancer Diagnosis and Therapeutics Market
Research and Analysis, by Region
The Report covers:
Comprehensive research methodology of global skin cancer
diagnosis and therapeutics
This report also includes detailed and extensive market
overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing
the market guided by key recommendations.
Analysis of regional regulations and other government
policies impacting the global skin cancer diagnosis and therapeutics
Insights about market determinants which are stimulating the
global skin cancer diagnosis and therapeutics
Detailed and extensive market segments with regional
distribution of forecasted revenues.
Extensive profiles and recent developments of market
players.
FOR MORE DETAILS -
https://www.wiseguyreports.com/reports/3186925-global-skin-cancer-diagnosis-and-therapeutics-market-research
About Us:
Wise Guy Reports is
part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium
progressive statistical surveying, market research reports, analysis &
forecast data for industries and governments around the globe.
Contact Us:
NORAH
TRENT
Ph:
+162-825-80070
(US)
Ph:
+44 203 500 2763 (UK)
Comments
Post a Comment